Market Closed -
OTC Markets
15:36:50 2024-02-16 EST
|
5-day change
|
1st Jan Change
|
8,000
USD
|
-3.03%
|
|
-.--%
|
-3.03%
|
Fiscal Period: September |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Capitalization
1 |
73.3
|
73.3
|
62.64
|
42.18
|
29.62
|
73.6
|
Enterprise Value (EV)
1 |
91.38
|
93.75
|
87.97
|
104.5
|
93.31
|
85.58
|
P/E ratio
|
6.07
x
|
-34.3
x
|
-7.37
x
|
-
|
-
|
-
|
Yield
|
6.18%
|
9.09%
|
-
|
-
|
-
|
15.2%
|
Capitalization / Revenue
|
0.33
x
|
0.34
x
|
0.29
x
|
0.21
x
|
0.1
x
|
0.19
x
|
EV / Revenue
|
0.42
x
|
0.44
x
|
0.41
x
|
0.53
x
|
0.31
x
|
0.22
x
|
EV / EBITDA
|
3.5
x
|
8.78
x
|
25.6
x
|
9.2
x
|
4.49
x
|
1.32
x
|
EV / FCF
|
9.05
x
|
19.4
x
|
15.9
x
|
-12.6
x
|
-13.1
x
|
2.24
x
|
FCF Yield
|
11%
|
5.17%
|
6.27%
|
-7.96%
|
-7.61%
|
44.6%
|
Price to Book
|
0.65
x
|
0.71
x
|
0.7
x
|
-
|
-
|
-
|
Nbr of stocks (in thousands)
|
13.3
|
13.3
|
13.3
|
8.98
|
8.98
|
8.98
|
Reference price
2 |
5,500
|
5,500
|
4,700
|
4,700
|
3,300
|
8,200
|
Announcement Date
|
12/15/17
|
12/14/18
|
12/20/19
|
12/11/20
|
12/23/21
|
12/9/22
|
Fiscal Period: September |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Net sales
1 |
219.8
|
215
|
217
|
198.6
|
302.8
|
387.1
|
EBITDA
1 |
26.12
|
10.68
|
3.44
|
11.35
|
20.78
|
65.01
|
EBIT
1 |
14
|
-0.765
|
-6.861
|
0.556
|
9.592
|
53.53
|
Operating Margin
|
6.37%
|
-0.36%
|
-3.16%
|
0.28%
|
3.17%
|
13.83%
|
Earnings before Tax (EBT)
1 |
13.44
|
-2.137
|
-8.497
|
-0.442
|
8.584
|
57.76
|
Net income
1 |
13.44
|
-2.137
|
-8.497
|
-0.442
|
8.584
|
57.76
|
Net margin
|
6.12%
|
-0.99%
|
-3.92%
|
-0.22%
|
2.83%
|
14.92%
|
EPS
2 |
906.3
|
-160.4
|
-637.6
|
-
|
-
|
-
|
Free Cash Flow
1 |
10.1
|
4.845
|
5.518
|
-8.32
|
-7.101
|
38.21
|
FCF margin
|
4.59%
|
2.25%
|
2.54%
|
-4.19%
|
-2.34%
|
9.87%
|
FCF Conversion (EBITDA)
|
38.64%
|
45.37%
|
160.4%
|
-
|
-
|
58.77%
|
FCF Conversion (Net income)
|
75.08%
|
-
|
-
|
-
|
-
|
66.15%
|
Dividend per Share
2 |
340.0
|
500.0
|
-
|
-
|
-
|
1,250
|
Announcement Date
|
12/15/17
|
12/14/18
|
12/20/19
|
12/11/20
|
12/23/21
|
12/9/22
|
Fiscal Period: September |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Net Debt
1 |
18.1
|
20.5
|
25.3
|
62.3
|
63.7
|
12
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
0.692
x
|
1.915
x
|
7.365
x
|
5.486
x
|
3.064
x
|
0.1844
x
|
Free Cash Flow
1 |
10.1
|
4.84
|
5.52
|
-8.32
|
-7.1
|
38.2
|
ROE (net income / shareholders' equity)
|
12.5%
|
-1.99%
|
-9.08%
|
-0.57%
|
12.2%
|
59.1%
|
ROA (Net income/ Total Assets)
|
5.82%
|
-0.33%
|
-3.03%
|
0.25%
|
4.03%
|
21.1%
|
Assets
1 |
231.2
|
651.5
|
280.9
|
-179.2
|
212.8
|
273.5
|
Book Value Per Share
2 |
8,403
|
7,743
|
6,701
|
-
|
-
|
-
|
Cash Flow per Share
2 |
112.0
|
108.0
|
80.70
|
-
|
-
|
-
|
Capex
1 |
7.71
|
5.56
|
9.81
|
8.34
|
8.26
|
4.76
|
Capex / Sales
|
3.51%
|
2.59%
|
4.52%
|
4.2%
|
2.73%
|
1.23%
|
Announcement Date
|
12/15/17
|
12/14/18
|
12/20/19
|
12/11/20
|
12/23/21
|
12/9/22
|
|
1st Jan change
|
Capi.
|
---|
| -3.03% | 71.8M | | +6.34% | 106B | | -10.78% | 59.59B | | +61.90% | 45.4B | | +14.54% | 38.12B | | +1.03% | 31.28B | | +9.32% | 19.67B | | +10.83% | 16.52B | | +7.90% | 13.8B | | -5.22% | 12.96B |
Other Commodity Chemicals
|